Scarica l'app Stockscreener
1.16
11.54%
0.12
Dopo l'orario di chiusura:
1.15
-0.01
-0.86%
Precedente Chiudi:
$1.04
Aprire:
$1.06
Volume 24 ore:
277.59K
Relative Volume:
1.15
Capitalizzazione di mercato:
$63.98M
Reddito:
$3.10M
Utile/perdita netta:
$-97.43M
Rapporto P/E:
-0.5225
EPS:
-2.22
Flusso di cassa netto:
$-94.38M
1 W Prestazione:
-6.45%
1M Prestazione:
+3.57%
6M Prestazione:
-55.04%
1 anno Prestazione:
-35.91%
Intervallo 1D:
$1.02
$1.18
Intervallo di 1 settimana:
$1.02
$1.35
Portata 52W:
$0.89
$6.30
Omega Therapeutics Inc Stock (OMGA) Company Profile
Nome
Omega Therapeutics Inc
Settore
Industria
Telefono
(617) 949-4360
Indirizzo
140 FIRST STREET, SUITE 501, CAMBRIDGE
Omega Therapeutics Inc Stock (OMGA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-12-08 | Iniziato | H.C. Wainwright | Buy |
| 2022-09-23 | Iniziato | Chardan Capital Markets | Buy |
Omega Therapeutics Inc Borsa (OMGA) Ultime notizie
Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace
Oculis Holding AG (OCS) Moves 7.9% Higher: Will This Strength Last? - Yahoo Finance
Zura Bio (NASDAQ:ZURA) versus Omega Therapeutics (NASDAQ:OMGA) Critical Contrast - Defense World
Omega Therapeutics stock hits 52-week low at $0.94 By Investing.com - Investing.com Australia
Cubist Systematic Strategies LLC Grows Holdings in Omega Therapeutics, Inc. (NASDAQ:OMGA) - Defense World
Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings - The Manila Times
Omega Therapeutics to Present Multiple Posters Highlighting - GlobeNewswire
Omega Therapeutics stock hits 52-week low at $0.94 - Investing.com
Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital Solutions - Financial Times
Omega Therapeutics stock hits 52-week low at $1.07 By Investing.com - Investing.com Australia
Omega Therapeutics stock hits 52-week low at $1.07 - Investing.com India
Omega Therapeutics Appoints New Director - Investing.com India
Omega Therapeutics Welcomes Robert Rosiello to Board - TipRanks
Omega Therapeutics Appoints New Director By Investing.com - Investing.com UK
Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors – Company Announcement - Financial Times
A*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in Singapore - Financial Times
Halda Therapeutics Appoints Veteran Biopharma Leader, Christian Schade, as President and Chief Executive Officer - Financial Times
Omega Therapeutics stock hits 52-week low at $1.2 By Investing.com - Investing.com Canada
Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry – Company AnnouncementFT.com - Financial Times
Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications - ForexTV.com
Omega Therapeutics reports tumor inhibition in liver cancer models - Investing.com
Omega Therapeutics Announces Publication of Epigenomic - GlobeNewswire
RNA-Based Therapeutics Market to Grow by USD 1.27 Billion (2024-2028) Due to Increased Investment and Funding, AI Trends Impacting RevenueTechnavio - The Malaysian Reserve
RNA-Based Therapeutics Market To Grow By USD 1.27 Billion (2024-2028) Due To Increased Investment And Funding, AI Trends Impacting RevenueTechnavio - MENAFN.COM
Omega Therapeutics (NASDAQ:OMGA) Stock Price Up 0.8% - MarketBeat
Omega Therapeutics (NASDAQ:OMGA) Shares Up 0.8% - Defense World
Omega Therapeutics stock hits 52-week low at $1.29 amid downturn - Investing.com Australia
A look into Omega Therapeutics Inc (OMGA)’s deeper side - SETE News
Omega Therapeutics inks shared space deals with Flagship affiliates - Investing.com
Omega Therapeutics inks shared space deals with Flagship affiliates By Investing.com - Investing.com South Africa
Novo Nordisk to meet Drug Demand with $220M Expansion - European Pharmaceutical Manufacturer
HC Wainwright Comments on Omega Therapeutics, Inc.'s Q3 2024 Earnings (NASDAQ:OMGA) - MarketBeat
HC Wainwright Analysts Boost Earnings Estimates for Omega Therapeutics, Inc. (NASDAQ:OMGA) - Defense World
Omega Therapeutics' (OMGA) Buy Rating Reiterated at HC Wainwright - MarketBeat
Omega Therapeutics appoints new SVP of Research By Investing.com - Investing.com Australia
A Glimpse Into The Expert Outlook On Omega Therapeutics Through 4 Analysts - Benzinga
Omega Therapeutics appoints new SVP of Research - Investing.com India
Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research - GlobeNewswire
Omega Therapeutics Appoints Jennifer Nelson, Ph.D., as Senior Vice President of Research - citybiz
Omega Therapeutics, Inc. (NASDAQ:OMGA) Forecasted to Post FY2024 Earnings of ($1.27) Per Share - MarketBeat
Omega Therapeutics’ (OMGA) “Outperform” Rating Reiterated at Wedbush - Defense World
Middle East & Africa Calcium Carbonate Market Size & Outlook, 2030 - Grand View Research
Wedbush Weighs in on Omega Therapeutics, Inc.'s Q3 2024 Earnings (NASDAQ:OMGA) - MarketBeat
Omega Therapeutics Inc Azioni (OMGA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.02%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):